Latest filing published 02 Sept 2020 for PCI Biotech Holding ASA, €20k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Per Walday: trading record in brief
Per Walday discloses dealings in PCI Biotech Holding ASA to Oslo Børs. In total, 4 filings cover trades dated from 21 December 2016 to 2 September 2020.
Both buying and selling appear: 1 purchase, against 3 sales worth €68k. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2020 to date brings no purchases and 1 sale.
The newest entry dates from 2 September 2020: an open-market sale of €20k, in PCI Biotech Holding ASA. The last insider purchase was made public on 20 September 2018, 2,971 days ago. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from Oslo Børs disclosures alone and does not predict where the share price will go.
Companies and markets linked to Per Walday
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,600 shares@ NOK 45.60OptionXOSLOSLO:512800
- OptionXOSLOSLO:459902Canonical exit: 19 Dec 2018 (T+90)
- 16,000 shares@ NOK 19.90OptionXOAXOSLO:434193
- 10,000 shares@ NOK 12.15OptionXOAXOSLO:416627
4 of 4 declarations